Cargando…
Lamin B1 regulates somatic mutations and progression of B-cell malignancies
Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we report that genome binding of Lamin B1, a component of the nuclear envelope involved in epi...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808072/ https://www.ncbi.nlm.nih.gov/pubmed/28804121 http://dx.doi.org/10.1038/leu.2017.255 |
_version_ | 1783299394325446656 |
---|---|
author | Klymenko, T Bloehdorn, J Bahlo, J Robrecht, S Akylzhanova, G Cox, K Estenfelder, S Wang, J Edelmann, J Strefford, J C Wojdacz, T K Fischer, K Hallek, M Stilgenbauer, S Cragg, M Gribben, J Braun, A |
author_facet | Klymenko, T Bloehdorn, J Bahlo, J Robrecht, S Akylzhanova, G Cox, K Estenfelder, S Wang, J Edelmann, J Strefford, J C Wojdacz, T K Fischer, K Hallek, M Stilgenbauer, S Cragg, M Gribben, J Braun, A |
author_sort | Klymenko, T |
collection | PubMed |
description | Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we report that genome binding of Lamin B1, a component of the nuclear envelope involved in epigenetic chromatin regulation, is reduced during B-cell activation and formation of lymphoid germinal centres. Chromatin immunoprecipitation-Seq analysis showed that kappa and heavy variable immunoglobulin domains were released from the Lamin B1 suppressive environment when SHM was induced in B cells. RNA interference-mediated reduction of Lamin B1 resulted in spontaneous SHM as well as kappa-light chain aberrant surface expression. Finally, Lamin B1 expression level correlated with progression-free and overall survival in chronic lymphocytic leukaemia, and was strongly involved in the transformation of follicular lymphoma. In summary, here we report that Lamin B1 is a negative epigenetic regulator of SHM in normal B-cells and a ‘mutational gatekeeper’, suppressing the aberrant mutations that drive lymphoid malignancy. |
format | Online Article Text |
id | pubmed-5808072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58080722018-02-14 Lamin B1 regulates somatic mutations and progression of B-cell malignancies Klymenko, T Bloehdorn, J Bahlo, J Robrecht, S Akylzhanova, G Cox, K Estenfelder, S Wang, J Edelmann, J Strefford, J C Wojdacz, T K Fischer, K Hallek, M Stilgenbauer, S Cragg, M Gribben, J Braun, A Leukemia Original Article Somatic hypermutation (SHM) is a pivotal process in adaptive immunity that occurs in the germinal centre and allows B cells to change their primary DNA sequence and diversify their antigen receptors. Here, we report that genome binding of Lamin B1, a component of the nuclear envelope involved in epigenetic chromatin regulation, is reduced during B-cell activation and formation of lymphoid germinal centres. Chromatin immunoprecipitation-Seq analysis showed that kappa and heavy variable immunoglobulin domains were released from the Lamin B1 suppressive environment when SHM was induced in B cells. RNA interference-mediated reduction of Lamin B1 resulted in spontaneous SHM as well as kappa-light chain aberrant surface expression. Finally, Lamin B1 expression level correlated with progression-free and overall survival in chronic lymphocytic leukaemia, and was strongly involved in the transformation of follicular lymphoma. In summary, here we report that Lamin B1 is a negative epigenetic regulator of SHM in normal B-cells and a ‘mutational gatekeeper’, suppressing the aberrant mutations that drive lymphoid malignancy. Nature Publishing Group 2018-02 2017-09-01 /pmc/articles/PMC5808072/ /pubmed/28804121 http://dx.doi.org/10.1038/leu.2017.255 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Klymenko, T Bloehdorn, J Bahlo, J Robrecht, S Akylzhanova, G Cox, K Estenfelder, S Wang, J Edelmann, J Strefford, J C Wojdacz, T K Fischer, K Hallek, M Stilgenbauer, S Cragg, M Gribben, J Braun, A Lamin B1 regulates somatic mutations and progression of B-cell malignancies |
title | Lamin B1 regulates somatic mutations and progression of B-cell malignancies |
title_full | Lamin B1 regulates somatic mutations and progression of B-cell malignancies |
title_fullStr | Lamin B1 regulates somatic mutations and progression of B-cell malignancies |
title_full_unstemmed | Lamin B1 regulates somatic mutations and progression of B-cell malignancies |
title_short | Lamin B1 regulates somatic mutations and progression of B-cell malignancies |
title_sort | lamin b1 regulates somatic mutations and progression of b-cell malignancies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808072/ https://www.ncbi.nlm.nih.gov/pubmed/28804121 http://dx.doi.org/10.1038/leu.2017.255 |
work_keys_str_mv | AT klymenkot laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT bloehdornj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT bahloj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT robrechts laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT akylzhanovag laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT coxk laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT estenfelders laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT wangj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT edelmannj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT streffordjc laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT wojdacztk laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT fischerk laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT hallekm laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT stilgenbauers laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT craggm laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT gribbenj laminb1regulatessomaticmutationsandprogressionofbcellmalignancies AT brauna laminb1regulatessomaticmutationsandprogressionofbcellmalignancies |